Roche Holding AG American Depositary Receipt logo

Roche Holding AG American Depositary Receipt (RHO0)

Market Closed
5 Jun, 20:00
XFRA XFRA
15. 90
+0.8
+5.298%
- Market Cap
17.54 P/E Ratio
10.85% Div Yield
2 Volume
0 Eps
15.1
Previous Close
Add Transaction
Day Range
15.9 15.9
Year Range
11.6 18.6
Want to track RHO0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

RHO0 closed Friday higher at €15.9, an increase of 5.298% from Thursday's close, completing a monthly decrease of -1.8519% or -€0.3. Over the past 12 months, RHO0 stock gained 4.6053%.
RHO0 is not paying dividends to its shareholders.
The last earnings report, released on Jan 28, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on NEO-L (CAD).

RHO0 Chart

Roche Holding AG American Depositary Receipt (RHO0) FAQ

What is the stock price today?

The current price is €15.90.

On which exchange is it traded?

Roche Holding AG American Depositary Receipt is listed on XFRA.

What is its stock symbol?

The ticker symbol is RHO0.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 10.85%.

What is its market cap?

As of today, no market cap data is available.

Has Roche Holding AG American Depositary Receipt ever had a stock split?

No, there has never been a stock split.

Roche Holding AG American Depositary Receipt Profile

Pharmaceuticals Industry
Healthcare Sector
Thomas Schinecker CEO
XFRA Exchange
- ISIN
CH Country
103,249 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Roche Holding AG is a global leader in healthcare, with a strong focus on pharmaceuticals and diagnostics. The company has a presence across Europe, North America, Latin America, Asia, Africa, Australia, and Oceania, showcasing a truly international footprint. Founded in 1896, Roche has a long-standing history of innovation and dedication to improving health outcomes. Based in Basel, Switzerland, this esteemed company has been at the forefront of developing and providing solutions to some of the most pressing health challenges faced around the world.

Products and Services

Roche Holding AG offers a broad portfolio of products and services, catering to a wide range of therapeutic areas and diagnostic needs:

  • Pharmaceutical Products

    These include a variety of medications aimed at treating conditions in therapeutic areas such as anemia, various types of blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune diseases, neurological disorders, ophthalmology, respiratory disorders, and transplantation. Roche is also actively developing new pharmaceutical products to address unmet medical needs in these and other areas.

  • In Vitro Diagnostic Tests

    Roche provides a comprehensive range of diagnostic tests for the detection of diseases like cancer, diabetes, Covid-19, hepatitis, human papillomavirus (HPV), among others. These diagnostic tools are essential in the early detection, diagnosis, and monitoring of diseases, leading to better patient outcomes.

  • Diagnostic Instruments

    The company also offers advanced diagnostic instruments used by laboratories, hospitals, and healthcare providers globally. These instruments are crucial for conducting the in vitro diagnostic tests, ensuring accuracy and efficiency in diagnostics.

  • Digital Health Solutions

    Understanding the increasing role of technology in healthcare, Roche is also involved in offering digital health solutions. These innovative technologies aim to improve patient care, enhance diagnostic and therapeutic processes, and enable healthcare providers to deliver more personalized and efficient care.

Contact Information

Address: Konzern Hauptsitz
Phone: 41 61 688 11 11